Your browser doesn't support javascript.
loading
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.
Fredman, Danielle; Moshe, Yakir; Wolach, Ofir; Heering, Gabriel; Shichrur, Keren; Goldberg, Idan; Hofstetter, Liron; Neaman, Miriam; Scheib, Tomer; Marcu-Malina, Victoria; Avigdor, Abraham; Shimoni, Avichai; Nagler, Arnon; Canaani, Jonathan.
Affiliation
  • Fredman D; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel Aviv University, 52621, Ramat-Gan, Israel.
  • Moshe Y; Hematology Department, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Wolach O; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Hod HaSharon, Israel.
  • Heering G; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel Aviv University, 52621, Ramat-Gan, Israel.
  • Shichrur K; Molecular Oncology Laboratory, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Goldberg I; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Hod HaSharon, Israel.
  • Hofstetter L; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Hod HaSharon, Israel.
  • Neaman M; Hematology Department, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Scheib T; Hematology Department, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Marcu-Malina V; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel Aviv University, 52621, Ramat-Gan, Israel.
  • Avigdor A; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel Aviv University, 52621, Ramat-Gan, Israel.
  • Shimoni A; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel Aviv University, 52621, Ramat-Gan, Israel.
  • Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel Aviv University, 52621, Ramat-Gan, Israel.
  • Canaani J; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel Aviv University, 52621, Ramat-Gan, Israel. Jonathan.Canaani@sheba.health.gov.il.
Ann Hematol ; 101(3): 581-593, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35088172
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Israel Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Israel Country of publication: Germany